Trial · NCT07902180
Benefits of cinEmA Sessions During Radio-chemoTherapy on Outcomes of Patients With ceRvIcal canCEr
NCT07902180, Not applicable, Recruiting, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Benefits of cinEmA Sessions During Radio-chemoTherapy on Outcomes of Patients With ceRvIcal canCEr. Trials, record NCT07902180. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902180
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Benefits of cinEmA Sessions During Radio-chemoTherapy on Outcomes of Patients With ceRvIcal canCEr
- NCT number
- NCT07902180
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 68 participants, estimated
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Conditions
- Cervical Cancer
- Interventions
- cinema session
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | effect of cinema on anxiety | 1 week | To evaluate if there is a difference in state anxiety between the EG (cinema) group and the TAU (treatment as usual) measured by STAI in Y1 form for the State Anxiety (State Trait Anxiety Inventory) - range score 20 - 80. Higher scores mean worse outcome. |
| Secondary | Quality of life outcomes | 1 week | Quality of life and psychological profile were assessed with the EORTC QLQ-C30, its cervical cancer module QLQ-CX24 and the PANAS (positive and negative emotions). C30 and CX24 items are scored 1-4 (C30 items 29-30: 1-7) and transformed to 0-100: higher scores indicate better global QoL and functioning (incl. CX24 sexual activity and enjoyment) but a greater burden on symptom scales (e.g. fatigue, pain; CX24 symptom experience, body image, sexual/vaginal functioning). CX24 sexual items apply only to sexually active women. The PANAS has two 10-item subscales, positive and negative affect, each scored 10-50; higher scores indicate greater affect. |
| Secondary | Salivary alpha-amylase (sAA) | 1 day | Salivary alpha-amylase (sAA), a marker of sympathetic stress activation, will be measured in U/mL at standardised times (no fixed range; higher values = greater activation). |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902180
GET https://conductscience.org/api/trials/v1/NCT07902180/registered